These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16882474)

  • 1. Regarding "prevalence of the metabolic syndrome in relation to self-reported cancer history".
    Polednak AP
    Ann Epidemiol; 2006 Dec; 16(12):877-9. PubMed ID: 16882474
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
    Sommer DM; Jenisch S; Suchan M; Christophers E; Weichenthal M
    Arch Dermatol Res; 2006 Dec; 298(7):321-8. PubMed ID: 17021763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
    Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
    J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome among postmenopausal women in Ecuador.
    Hidalgo LA; Chedraui PA; Morocho N; Alvarado M; Chavez D; Huc A
    Gynecol Endocrinol; 2006 Aug; 22(8):447-54. PubMed ID: 17012107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of insulin resistance syndrome in a primary health care center in Kuwait.
    Al-Shaibani H; El-Batish M; Sorkhou I; Al-Shamali N; Al-Namash H; Habiba S; Al-Qallaf B
    Fam Med; 2004 Sep; 36(8):540. PubMed ID: 15343411
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of metabolic syndrome with microalbuminuria in non-hypertensive type 2 diabetic patients.
    Lee JE; Huh W; Son HJ; Kim YG; Kim DJ; Lee MK; Oh HY
    Nephron Clin Pract; 2007; 106(3):c98-103. PubMed ID: 17522477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study.
    Kelishadi R; Cook SR; Motlagh ME; Gouya MM; Ardalan G; Motaghian M; Majdzadeh R; Ramezani MA
    J Am Diet Assoc; 2008 Jan; 108(1):82-90. PubMed ID: 18155992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and treatment of metabolic syndrome in adolescents with type 2 diabetes.
    Sanders BH; Lubsch LM; West DS
    Ann Pharmacother; 2006 Sep; 40(9):1517-21. PubMed ID: 16896016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome prevalence and characteristics in Greek adults with familial combined hyperlipidemia.
    Skoumas J; Papadimitriou L; Pitsavos C; Masoura C; Giotsas N; Chrysohoou C; Toutouza M; Panagiotakos D; Stefanadis C
    Metabolism; 2007 Jan; 56(1):135-41. PubMed ID: 17161236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
    J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
    Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
    Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prevalence of impaired glucose tolerance in life-style related disease].
    Tomono S; Utsugi T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():78-81. PubMed ID: 15779349
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diabetes and erectile dysfunction in Morocco: epidemiological study among outpatients].
    El AY; Berraho M; Benslimane A; Chrit M; El Hassani H; Lyoussi B; Nejjari C
    East Mediterr Health J; 2008; 14(5):1090-100. PubMed ID: 19161081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of microvascular complications in metabolic syndrome in comparison to type 2 diabetes mellitus.
    Ahamed A; Shantha GP; Agarwal G; Senthil N; Paunikar N; Sudhakar MK
    J Indian Med Assoc; 2008 Sep; 106(9):583-4, 586, 588. PubMed ID: 19552085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.